Bellevue Life Sciences Acquisition (BLACW) Stock Price, News & Analysis

Company Overview

Bellevue Life Sciences Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquire companies in the healthcare industry. The company was founded in 2020 and is based in Bellevue, Washington. Bellevue Life Sciences Acquisition Corp. operates as a subsidiary of Bellevue Global Life Sciences Investors LLC.

Key Stats

• Today's Range: $0.03 to $0.03
• 50-Day Range: $0.02 to $0.04
• 52-Week Range: $0.01 to $0.06
• Volume: 200 shs
• Average Volume: 30,455 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

BLACW Stock Analysis - Frequently Asked Questions

How have BLACW shares performed this year?

Bellevue Life Sciences Acquisition's stock was trading at $0.0199 at the beginning of the year. Since then, BLACW stock has increased by 73.4% and is now trading at $0.0345.
View the best growth stocks for 2024 here.

How do I buy shares of Bellevue Life Sciences Acquisition?

Shares of BLACW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Financial Services
• Industry: Shell Companies
• Sub-Industry: N/A
• Current Symbol: NASDAQ:BLACW
• CUSIP: N/A
• CIK: 1840425
• Web: N/A
• Phone: 425-635-7700
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A